Skip to content

Exercise related risks during the Nijmegen 4-Day Marches: the influence of overweight

Exercise related risks during the Nijmegen 4-Day Marches: the influence of overweight - Weight related risks during the 4-Day Marches

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON33248
Enrollment
150
Registered
2009-06-15
Start date
2009-06-15
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inspannings gerelateerde gezondheidsrisico's (thermoregulatie, vocht- en electrolytenbalans) heat related problems

Interventions

None listed

Sponsors

Universitair Medisch Centrum Sint Radboud
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - older than 18 years - Group 1: participant of 4-Day marches / BMI30 - Group 3: non-participant of 4-Day marches/ inactive (30

Exclusion criteria

Exclusion criteria: obstructive disease of the gastro-intestinal tract, including diverticulitis and inflammatory bowel disease - previous gastrointestinal surgery, except cholecystectomy and appendectomy - MRI during the period that the CorTemp sensor is within the body (e.g. 1 day preceding the 4-Day Marches, during the 4-Day Marches and 2 days after the the 4-Day Marches) - subject having a cardiac pacemaker or other implanted electromedical device.

Design outcomes

Primary

MeasureTime frame
1) Blood determinations (lipid- and insulin profile, electrolytes, hematocrit, hemoglobine, creatine kinase, troponin) 2) Fluid intake and urine output 3) Core body temperature, skin temperature and heart rate 4) Energy expenditure 5) Personal characteristics (questionnaire) 6) Blood vessel quality (IMT of the a. carotis) 7) Ambient conditions

Secondary

MeasureTime frame
1) Urine analysis 2) Body weight (changes) 3) General characteristics 4) Blood pressure

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)